Pharmaceutical

Listen: Sarepta’s pivotal moment, biotech’s big week, &...

How can you be sure a gene therapy is working? What does $11 billion get you in ...

STAT+: HCA, Louisiana hospital system sue FTC over revi...

HCA Healthcare and LCMC Health each sued the FTC and the DOJ, saying the antitru...

Epic and Microsoft’s AI collaboration, Amazon and 3M, &...

In the latest edition of STAT's Health Tech newsletter: Epic and Microsoft's AI ...

STAT+: Narcan manufacturer aims to price over-the-count...

While many addiction and overdose experts celebrated its new over-the-counter st...

Biden to tap head of National Cancer Institute to lead NIH

President Biden will nominate oncologist Monica Bertagnolli, director of the Nat...

STAT+: Powerful Senate duo drops a bipartisan PBM refor...

Senate Finance Committee leaders unveiled a bipartisan list of reforms to PBM's ...

STAT+: Pharmalittle: White House to tap cancer center c...

The White House plans to nominate Monica Bertagnolli, director of the National C...

STAT+: The high hopes — and high stakes — behind Micros...

A pilot at three large health systems will use generative AI to help doctors res...

Stock drama, cancer vaccine success, and new science — ...

There was some drama at the American Association for Cancer Research annual meet...

Opinion: Judicial overreach is an immediate hazard to a...

It is reckless for courts to make decisions that disregard decades of clinical e...

Tubulis and Bristol Myers Squibb agree to develop ADCs ...

Bristol Myers Squibb will be solely responsible for the development, production ...

Targovax announces plans to rebrand as Circio

Circio will initially focus on developing new circRNA medicines for cancer, with...

Zucara Therapeutics receives FDA IND approval for ZT-01

The FDA IND approval allows Zucara to begin its Phase IIa ZONE trial of ZT-01 in...

Maxion scoops £2m UK grant to develop autoimmune diseas...

The grant was awarded as part of an Innovate UK competition and will support Max...

DBV sets course on regulatory journey for peanut allerg...

Following several setbacks, the DBV now has received guidance to submit addition...

Abdera raises funds to advance radiopharmaceuticals to ...

Abdera’s ROVEr platform facilitates the development of next-generation antibody-...